Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment

Detalles Bibliográficos
Autores principales: Agersnap, Mikkel Askjær, Sonne, Kim, Knudsen, Kim Mark, Sulowicz, Wladyslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085895/
https://www.ncbi.nlm.nih.gov/pubmed/36913139
http://dx.doi.org/10.1007/s40262-023-01236-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085895/
https://www.ncbi.nlm.nih.gov/pubmed/36913139
http://dx.doi.org/10.1007/s40262-023-01236-4

Ejemplares similares